๐ฌJust published in @asnpublications In a mouse model of #ADTKD-UMOD, moderate calorie restriction restores autophagy, reduces ER retention of mutant #uromodulin, and significantly delays kidney disease.
https://t.co/w0TLarLkmT
Very proud of @DanieleRitis, a super talented postdoc in my lab, who has been awarded with the Cariplo grant for young researchers on a project ai med at testing our gene therapy approach in #ARSACS preclinical models.
https://t.co/o8EMpr81QS
Recherche publiรฉe dans 'Annals of Neurology' en 2024 / Research published in 'Annals of Neurology' in 2024.
โLongitudinal Imaging Biomarkers Correlate with Progressive Motor Deficit in the Mouse Model of Charlevoix-Saguenay Ataxiaโ.
https://t.co/wnuqaUD8Wd
Happy to share our last paper on Annals of Neurology, identifying non invasive longitudinal biomarkers of disease progression in the ARSACS mouse model
https://t.co/ZTEsxfcTZY
The 2024 International Congress for Ataxia Research (#ICAR2024) kicks off today in London, bringing together 600+ researchers and professionals from 32 countries to advance #ataxia research and treatments.
https://t.co/CaGN8We2m1
๐๐ฃ Save the date!
๐ ๐งฌ Dal 25 al 27 ottobre 2024, torna a Padova la XIV edizione del ๐๐จ๐ง๐ฏ๐๐ ๐ง๐จ ๐๐๐ณ๐ข๐จ๐ง๐๐ฅ๐ ๐ฌ๐ฎ๐ฅ๐ฅ๐ ๐๐๐ฅ๐๐ญ๐ญ๐ข๐ ๐๐ข๐ญ๐จ๐๐จ๐ง๐๐ซ๐ข๐๐ฅ๐ข.
๐ Prenota il tuo posto al link:
https://t.co/gCLg7C9OEM
Nuove prospettive nella ricerca sulla SPAX5: Sephin-1 come possibile terapia. Leggi l'articolo per saperne di piรน sul nuovo studio dei ricercatori di @SanRaffaeleMI e UniSR ๐https://t.co/RVqyBq5lwx
Congratulations to @FrancescaMalt12 & her team for their recently published paper in Brain! In this NAF-funded project, they examined how activation of the integrated stress response improves mitochondrial health in Spastic Ataxia type 5 (SPAX5) cells. (1/3)